Self-monitoring of blood glucose in people with type 2 diabetes: Canadian diabetes association briefing document for healthcare providers

摘要

The Canadian Diabetes Association (CDA) believes that self-monitoring of blood glucose (SMBG) is an important and essential tool for the care of individuals with diabetes. The Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada (1) recommend that SMBG be individualized for each person with diabetes based on their circumstances and needs. It is the intent of the CDA to inform Canadian healthcare providers of its position concerning SMBG, to respect the CDA guidelines (1) and to proactively influence public policy concerning SMBG, while at the same time addressing issues concerning cost-effectiveness raised by the Canadian Optimal Medication Prescribing and Utilization Service (COMPUS) (2-7). To do this, a working group of members of the Clinical & Scientific Section (C&SS), Diabetes Educator Section (DES) and National Advocacy Committee (NAC) of the CDA was formed to draft a briefing document regarding SMBG. This document has been accepted by the executive committees of both the C&SS and DES.